Goldman Sachs Closes $650M Fund to Invest in 'Golden Era' of

Goldman Sachs’s new fund—its first dedicated to life sciences—will focus on early- to mid-stage therapeutics companies with multiple assets. Genetic medicine, cell therapy, immunotherapy, and artificial intelligence are among the areas of investment interest for the firm.

Related Keywords

Amit Sinha , Life Sciences Investing Group , Life Sciences , Sachs Asset Management , West Street Life Sciences , Nested Therapeutics , Weight Loss , Obesity , Verweight , Diabetes , Massachusetts , Medical Devices , Startups , Healthcare Innovation , Medcity News , San Francisco , Accelerator , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Dc , Healthcare It , Washington , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Cambridge , Dealflow , Hospitals , Wellpoint , Ealthways , Ealth And Wellness , Mployee Wellness Programs , Investing , Wellness , Medtronic , Hanghai Innovation Center , China , R D , Mdt , Minneapolis , Minnesota , Publics , Twin Cities , Ulcerative Colitis , Abbott Labs , Humira , Doctors , Pharmaceuticals , Skin Disorders , D Anderson Cancer Center , Cancer , Texas , Renal Denervation , St Jude Medical , Stj , Emr , Hr , Electronic Health Records , Electronic Medical Records , Certified Emr , Ehr , Advanced Cellular Technology , Amyotrophic Lateral Sclerosis , Embryonic Stem Cells , Geron Corporation , Lou Gehrigs Disease , Macular Degeneration , Regenerative Medicine , Spinal Cord Damage , Value Based Healthcare System , Obamacare , Ee For Service Model , California , Cleveland , Health Insurance , Insurance , Ohio , Pennsylvania , Politics , Cancer Treatment Options Library , Aetna , Pet , Aet , Health It , Phi , Philadelphia , Artificial Intelligence , Cell Therapy , Goldman Sachs , Immunotherapy , Precision Medicine , ,